Our new data released today focuses on the top anti-chemical antibodies and their targets. The majority of antibodies are raised against proteins – but some are raised against other molecules, which we term anti-chemical antibodies. CiteAb Product Manager Rhys Williams said: “To produce this dataset we looked at 2700 citations for antibodies raised against chemicals, […]
New data from CiteAb reveals that just nine companies supply the top 100 antibodies cited over the whole of 2016. In addition, one single company is responsible for the supply of 38 of these antibodies. Dr Andrew Chalmers, founder of CiteAb, said: “This data comes from a set that shows trends in citation rates for […]
Following our blog last week about our new custom antibody dataset, today we’re going to look at this data in a little more detail, focusing on the top targets for custom antibodies. Our custom antibody data helps suppliers identify antibodies to license in, but also gives us a great insight to trends in the market. […]
In a first for CiteAb, today we’re taking a first look at the global custom antibody market and we’ll be highlighting those suppliers claiming the largest share. CiteAb founder Dr Andrew Chalmers said: “As you know, we specialise in collating citations for catalogue antibodies, however over the last few months our team has been taking […]
Last week we reported on our brand new text mining technology developed by our team here at CiteAb. Today we’re looking at some very specific data we can access as a result of this new technology – insights into the antibodies used in prostate cancer research. CiteAb developer Matt Helsby said: “Using this new text […]
Today we return to our first ever data report, released three years ago, when we claimed that China was a market no supplier could ignore, and we look at new data to see whether our predictions came true. Back in 2014 we stated that ‘the data suggests that China is set to claim the lion’s […]
We recently announced that our team here at CiteAb has expanded our platform to cover multiple reagent types, and today we’re taking a first look at some of our new data. The inhibitors and activators used by life scientists to investigate cellular processes are collectively termed as ‘chemical probes’. They provide vital tools for […]
New to our series of blogs on antibody research applications, today we are exploring the top targets for ICC, or immunocytochemistry. ICC is the staining and microscopic examination of cells, which are often grown in culture. This is not to be confused with immunohistochemistry (IHC), which involves the staining of tissues with their normal organisation […]
As the vast majority of commercial antibodies are raised against human proteins, we became interested in taking a look at which commercial antibodies are being used by the zebrafish research community. Is the zebrafish research community using a subset of specialist antibodies raised for zebrafish research, or is it relying on anti-human antibodies cross reacting? […]
For the first time in 42 years, use of monoclonal antibodies has overtaken polyclonals in the research antibody market. Production of monoclonal antibodies was first described by Georges Köhler and César Milstein in 1975, and the pair were awarded the Nobel Prize in 1984. Monoclonal antibodies then became the dominant antibodies used in therapeutic and […]
CiteAb is the largest citation-ranked antibody search engine and database. It provides an impartial way to find and compare antibodies that work.
We use our database of antibody publications to produce unique antibody market data, income from this data allows us to remain free to list and impartial.
Publication metadata is provided by PubMed®, a database of the US National Library of Medicine.
PubMed® is a registered trademark of US National Library of Medicine.
Company registered in England #08530854. VAT #179706954.
In partnership with
© CiteAb 2012-2015. All Rights Reserved.